Pomdoctor Limited (NASDAQ:POM)
| Market Cap | 3.81M-97.7% |
| Revenue (ttm) | 345.02M |
| Net Income | -288.80M |
| EPS | -171.57 |
| Shares Out | 2.11M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 28,415,557 |
| Open | 0.95 |
| Previous Close | 0.66 |
| Day's Range | 0.69 - 1.86 |
| 52-Week Range | 0.43 - 115.74 |
| Beta | 2.28 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About POM
Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a digital portal that connects patients with medical professionals and essential medications. Pomdoctor's operations largely encompass both a virtual hospital model and a comprehensive pharmaceutical supply chain, thus linking individual users, pharmacies, distributors, medical experts, and other healthcare stakeholders. This enterprise was established in 2010 and is headquartered in Guangzhou, China.
$POM stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in POM holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by POM's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
POM Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New POM patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to POM from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in POM
| ETF | Est. Holding Size |
|---|---|
| HFXEIQ 50 Percent Hedged FTSE Europe ETF | $1.89K |
Estimated from each fund’s disclosed top holdings × AUM
POM Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from POM’s recent data — informational, not investment advice
Recent Insider Activity
No Form 4 filings in the last 90 days.